{
  "ticker": "JNJ",
  "target_date": "2025-05-27",
  "actual_date": "2025-05-27",
  "collected_at": "2025-12-08T11:48:52.262492",
  "price": {
    "open": 150.45,
    "high": 151.95,
    "low": 149.87,
    "close": 151.17349243164062,
    "volume": 6990700,
    "change_1d_pct": 1.06,
    "change_7d_pct": 3.31,
    "change_30d_pct": 1.87
  },
  "technicals": {
    "rsi_14": 50.19,
    "sma_20": 150.07,
    "sma_50": 152.42,
    "macd": -0.817,
    "macd_signal": -1.178,
    "macd_histogram": 0.36,
    "bb_upper": 155.47,
    "bb_lower": 144.68,
    "price_vs_sma20_pct": 0.73,
    "price_vs_sma50_pct": -0.82,
    "volume_ratio": 0.88
  },
  "fundamentals": {
    "market_cap": 489327853568,
    "pe_ratio": 19.604248,
    "forward_pe": 19.160378,
    "price_to_book": 6.1644464,
    "price_to_sales": 5.310181,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.27,
    "pct_from_52w_low": 44.37
  },
  "macro": {
    "spy": {
      "price": 587.78,
      "change_1d_pct": 2.08,
      "change_7d_pct": -0.51
    },
    "vix": {
      "level": 18.96,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.43
    },
    "dollar_index": {
      "level": 99.52
    },
    "gold": {
      "price": 3299.1
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Best Dividend Aristocrats For June 2025",
      "source": "SeekingAlpha",
      "datetime": 1748384108,
      "summary": "Investors should focus on Aristocrats with strong dividend growth, undervaluation, and high expected returns, but conduct their own due diligence. See more here.",
      "url": "https://finnhub.io/api/news?id=6ee1dcf91ffbd2bdde319f8234879fe63c615bdeedf7461a4dbb0c871beb6455"
    },
    {
      "headline": "Prothena: Despite Phase 3 Trial Failure, Other Neurodegenerative Programs In Place",
      "source": "SeekingAlpha",
      "datetime": 1748360877,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=cc007612ccff6c3d3a92a4c004d50f3b0433ec6287a08cca0b137bde8e86d895"
    },
    {
      "headline": "1 Top Dividend Stock to Buy for a Lifetime of Passive Income",
      "source": "Yahoo",
      "datetime": 1748345400,
      "summary": "The healthcare leader has a solid and diversified business that can overcome these headwinds.  J&J has increased its dividend for 62 consecutive years.  There are hundreds of dividend stocks on the market, but they don't all offer the same level of security.",
      "url": "https://finnhub.io/api/news?id=f5d1c0970f02aff811fe79e565b22bcbf2023e0471043eba9edbffa4e194b5ba"
    },
    {
      "headline": "J&J Bankruptcy Filing Dismissed: The Third Time's Not A Charm (Video)",
      "source": "Finnhub",
      "datetime": 1748340675,
      "summary": "self In this episode of the Lowenstein Bankruptcy Lowdown, Colleen M. Restel and Eric James Seltzer unpack the dismissal of Johnson &...",
      "url": "https://finnhub.io/api/news?id=6b0b902056a4418b0265577f65d1235aaed4f871f97447764c18078f659befcb"
    },
    {
      "headline": "BNY Mellon Income Stock Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1748340060,
      "summary": "BNY Mellon Income Stock Fund (Class A at NAV) returned 3.11% during the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=daa65f5c3dbc517f6c21c1e66b32a2b50aec8c1b7dc22bd14c2abe6bbb05afde"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}